data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

My Account

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Arcosa Inc

(NYSE:ACA)

$72.62

-1.17[-1.59%]

Last update: 3:59PM (Delayed 15-Minutes)
Get Real Time Here

$72.64

0.0200[0.03%]

Open73.100	Close72.640
Vol / Avg.166.881K / 244.424K	Mkt Cap3.541B
Day Range72.620 - 73.670	52 Wk Range52.040 - 79.380

0

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Latest News for Arcosa Stock (NYSE:ACA)

Arcosa Stock (NYSE: ACA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 18, 2023

President & CEO of Arcosa Makes $643K Sale
Benzinga Insights - Aug 18, 2023, 11:02AM

Thursday, August 17, 2023

Arcosa Recent Insider Activity
Benzinga Insights - Aug 17, 2023, 11:03AM

Tuesday, August 08, 2023

Stephens & Co. Maintains Equal-Weight on Arcosa, Raises Price Target to $87
Benzinga Newsdesk - Aug 8, 2023, 9:13AM

Monday, August 07, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $90
Benzinga Newsdesk - Aug 7, 2023, 1:17PM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $88
Benzinga Newsdesk - Aug 7, 2023, 12:46PM

Thursday, August 03, 2023

Arcosa Sees FY23 Revenue $2.25B-$2.30B vs $2.26B Est.
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Arcosa Q2 EPS $0.76 Beats $0.59 Estimate, Sales $584.80M Beat $575.68M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:43PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Thursday, July 13, 2023

CORRECTION: Acadia Pharmaceuticals Ticker Is 'ACAD'
Benzinga Newsdesk - Jul 13, 2023, 4:11PM

Friday, May 26, 2023

Arcosa Group President Sold $331K In Company Stock
Benzinga Insights - May 26, 2023, 11:04AM

Friday, May 19, 2023

Arcosa Group President Trades $594K In Company Stock
Benzinga Insights - May 19, 2023, 11:04AM

Monday, May 08, 2023

Where Arcosa Stands With Analysts
Benzinga Insights - May 8, 2023, 3:01PM
Oppenheimer Maintains Outperform on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 8, 2023, 8:28AM

Monday, May 01, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $85
Benzinga Newsdesk - May 1, 2023, 9:41AM
Loop Capital Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - May 1, 2023, 9:37AM

Friday, April 28, 2023

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
Lisa Levin - Apr 28, 2023, 10:44AM
Arcosa shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results and issued FY23 revenue guidance above analyst estimates.
Benzinga Newsdesk - Apr 28, 2023, 10:06AM

Thursday, April 27, 2023

CORRECTION: Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Benzinga Newsdesk - Apr 27, 2023, 5:16PM
Arcosa Sees FY23 Revenue $2.2B-$2.3B Vs $2.19B Est.
Happy Mohamed - Apr 27, 2023, 4:19PM
Arcosa Q1 Adj $1.06 Beats $0.55 Estimate, Sales $549.20M Beat $500.13M Estimate
Happy Mohamed - Apr 27, 2023, 4:18PM
Earnings Scheduled For April 27, 2023
Benzinga Insights - Apr 27, 2023, 7:37AM

Wednesday, April 26, 2023

Arcosa's Earnings Outlook
Benzinga Insights - Apr 26, 2023, 12:01PM

Monday, February 27, 2023

DA Davidson Maintains Buy on Arcosa, Raises Price Target to $80
Benzinga Newsdesk - Feb 27, 2023, 10:00AM

Friday, February 24, 2023

12 Industrials Stocks Moving In Friday's Intraday Session
Benzinga Insights - Feb 24, 2023, 12:31PM
Arcosa shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
Benzinga Newsdesk - Feb 24, 2023, 11:07AM

Thursday, February 23, 2023

Arcosa Sees FY23 Revenue $2.15B-$2.25B Vs $2.15B Est
Happy Mohamed - Feb 23, 2023, 4:24PM
Arcosa Q4 EPS $0.24 Beats $0.21 Estimate, Sales $500.30M Beat $477.67M Estimate
Happy Mohamed - Feb 23, 2023, 4:23PM
Earnings Scheduled For February 23, 2023
Benzinga Insights - Feb 23, 2023, 5:18AM

Thursday, December 08, 2022

Arcosa Renews $50M Share Repurchase Authorization
Benzinga Newsdesk - Dec 8, 2022, 4:19PM

Friday, November 18, 2022

Arcosa Recent Insider Activity
Benzinga Insights - Nov 18, 2022, 10:01AM

Tuesday, November 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Benzinga Insights - Nov 8, 2022, 9:43AM
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Lisa Levin - Nov 8, 2022, 6:19AM
Stephens & Co. Downgrades Arcosa to Equal-Weight, Lowers Price Target to $65
Benzinga Newsdesk - Nov 8, 2022, 4:48AM

Wednesday, November 02, 2022

Arcosa Q3 EPS $0.70 Beats $0.62 Estimate, Sales $603.90M Beat $581.37M Estimate
Benzinga Newsdesk - Nov 2, 2022, 4:54PM
Earnings Scheduled For November 2, 2022
Benzinga Insights - Nov 2, 2022, 4:37AM

Monday, October 17, 2022

11 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 17, 2022, 8:08AM
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin - Oct 17, 2022, 7:30AM
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Oct 17, 2022, 6:30AM

Monday, October 03, 2022

Shares of companies in the industrials sector are trading higher as stocks rebound following recent weakness.
Benzinga Newsdesk - Oct 3, 2022, 2:52PM

Monday, August 08, 2022

Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Benzinga Newsdesk - Aug 8, 2022, 9:20AM

Friday, August 05, 2022

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Lisa Levin - Aug 5, 2022, 6:12AM
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Lisa Levin - Aug 5, 2022, 4:00AM

Thursday, August 04, 2022

Arcosa shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
Bill Haddad - Aug 4, 2022, 1:56PM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 4, 2022, 1:12PM

Wednesday, August 03, 2022

Arcosa Sees FY22 Revenue Guidance $2.2B-$2.3B Vs $2.18B Est., Adj. EBITDA $325M-$345M
Michael Horton - Aug 3, 2022, 4:57PM
Arcosa Q2 Adj. EPS $0.83 Beats $0.46 Estimate, Sales $602.80M Beat $547.13M Estimate
Michael Horton - Aug 3, 2022, 4:56PM
Earnings Scheduled For August 3, 2022
Benzinga Insights - Aug 3, 2022, 4:30AM

Thursday, June 16, 2022

Shares of several companies in the broader industrials sector are trading lower amid overall market weakness as stocks fall following yesterday's Fed rate hike, which has pressured markets.
Benzinga Newsdesk - Jun 16, 2022, 10:36AM

Thursday, May 05, 2022

Shares of several companies in the broader industrial sector are trading lower amid market weakness as traders continue to digest Wednesday's Fed rate hike announcement.
Benzinga Newsdesk - May 5, 2022, 2:41PM

Thursday, April 28, 2022

Arcosa Narrows FY22 Adj. EBITDA Guidance From $280M-$305M To $290M-$305M
Benzinga Newsdesk - Apr 28, 2022, 5:03PM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved